Related Experiment Videos

Relationship between medication use and cardiovascular disease health outcomes in the Jackson Heart Study

Clifton C Addison1, Brenda W Jenkins, Daniel Sarpong

  • 1Jackson Heart Study/Project Health, Jackson State University, 350 W. Woodrow Wilson Drive, Suite 701, Jackson, MS 39213, USA. clifton.addison@jsums.edu

International Journal of Environmental Research and Public Health
|July 22, 2011
PubMed

Insights

Many African Americans do not adhere to prescribed cardiovascular disease (CVD) medications due to various reasons, including side effects and forgetfulness. Improving communication with healthcare providers can enhance medication adherence and health outcomes.

Area of Science:

  • Cardiovascular Health
  • Public Health
  • Medical Adherence

Background:

  • Cardiovascular disease (CVD) remains a significant health concern, particularly within the African American population.
  • Non-adherence to prescribed medications is a widespread issue negatively impacting treatment efficacy for conditions like atherosclerosis.
  • Despite available treatments, many at-risk individuals do not benefit due to poor adherence to medical advice.

Purpose of the Study:

  • To investigate the association between demographic factors, behavioral patterns (including medication adherence), and health outcomes in African Americans.
  • To identify common reasons for non-adherence to cardiovascular medications in this population.
  • To inform strategies for improving medication compliance and health outcomes.

Main Methods:

  • Utilized data from standardized interviews of 5301 African Americans in the Jackson Heart Study.
  • Collected data on medication use (blood pressure, cholesterol, diabetes, blood thinners) and reasons for non-adherence.
  • Analyzed demographic parameters, behavioral factors, and health outcomes.

Main Results:

  • Nearly 52% reported taking blood pressure medication, 14% cholesterol, 16% diabetes, and 19% blood-thinning medication.
  • Primary reasons for non-adherence included being busy/forgetful (47%), attempting to manage without medication (23%), cost (18%), side effects (19%), and functional impairment (17%).
  • Unacceptable secondary effects were a significant driver of non-compliance.

Conclusions:

  • The African American population can benefit from increased awareness of CVD risk factors and treatment benefits.
  • Addressing medication side effects through open communication with healthcare providers is crucial for improving adherence.
  • Enhanced patient-provider communication can lead to better-tolerated regimens, increased compliance, and improved cardiovascular health outcomes.

Keywords:
African-AmericansJackson Heart Studycardiovascular diseasemedication useminority

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...